← Back

EC Pharmaceutical Strategy · EU-wide · 7 Jul 2026 · News & press

DG SANTE and EMA sign Working Arrangement with New Zealand Ministry of Health

AI-generated summary

DG SANTE and the European Medicines Agency signed a Working Arrangement with New Zealand's Ministry of Health to strengthen collaboration on medicinal products. The agreement facilitates information exchange on drug quality, safety and efficacy, increases coordination on medicines regulation, and enables mutual learning and capacity building in regulatory science. The arrangement takes effect 6 July 2026.

From EC Pharmaceutical Strategy

DG SANTE and the European Medicines Agency (EMA) have signed a Working Arrangement with New Zealand Ministry of Health (incorporating the New Zealand Medicines and Medical Devices Safety Authority - Medsafe) this week, to strengthen collaboration and exchange of information on medicinal products. The agreement was signed by DG SANTE Director-General Sandra Gallina and EMA Executive Director Emer Cooke. Director-General Audrey Sonerson signed for the New Zealand Ministry of Health.

The purpose of this Working Arrangement is to strengthen cooperation between signatories across a range of areas in public health, while promoting the timely, secure exchange of information. Deliverables from the Arrangement will include:

- Facilitate exchange of information regarding medicinal products quality, safety and efficacy.

- Increase alignment and coordination on topics related to medicinal products for human-use, in-line with the application legislation.

- Mutual learning, capacity building and the sharing of best practices in regulatory science and public health.

The Arrangement will run from 6 July 2026.

Excerpt from the official page. The original is authoritative.